Home urine testing cuts bladder cancer deaths

	Tweet

A test for blood in the urine, which is easily performed at home, can lead to the detection of bladder cancers at an earlier, more curable stage, according to study findings presented this week at the annual meeting of the American Urological Association in Atlanta.

The test involves a chemical strip that changes color when placed in urine containing blood. While the test misses very few bladder cancers, it may also pick up non-cancerous disease that can cause blood in the urine, such as kidney stones.

In an earlier study, “we had shown that screening for (blood in the urine) at home with chemical reagent strips promoted the detection of bladder cancers at early stages,” lead author Dr. Edward M. Messing, from the University of Rochester in New York, told Reuters Health. “Now, we show that it can also reduce bladder cancer” deaths.

The current study involved 1575 men who performed home urine screening for 14 days, 2 months apart. The outcomes of men with screen-detected bladder cancers were then compared with those of unscreened men with bladder cancer entered in the Wisconsin Cancer Reporting System in 1988.

Twenty-one men in the screened group were found to have bladder cancer and their outcomes were compared with those of 509 men in the Wisconsin database.

Similar proportions of men with aggressive cancers were noted in each cohort. However, just 10 percent of the aggressive cancers in the screen-detected group actually invaded the bladder wall compared with 60 percent in the unscreened group. Once the cancer has invaded the bladder wall, the surgery used becomes more complicated and the chance for cure drops.

At a follow-up period of around 14 years, no bladder cancer deaths were noted in the screened group. By contrast, 20 percent of men died from bladder cancer in the unscreened group with a survival period of about 1.8 years from diagnosis.

Largely because of the drop in bladder cancer deaths, the overall death rate was also lower in the screened group: 43 versus 74 percent.

While the current findings are encouraging, specially designed comparison “trials are needed to confirm the benefits of home (urine) testing,” Messing said. In addition, “since our studies were conducted a number of bladder cancer markers have been identified that may improve the specificity of testing,” allowing doctors to differentiate bladder cancer from kidney stones, he added. 

RELATED STORIES:
Cholesterol drug inhibits cancer cells in lab   Variation in prostate stem cell antigen gene raises bladder cancer risk   Certain Ecologic Factors Associated with Greater Risk of Bladder Cancer   Women in nursing homes often have bladder problems   Bladder Cancer Study Determines Optimal Treatment   Less bladder cancer in frequent painkiller users   Bladder cancer: Need for a standardized protocol of management   Brochure Helps Patients Understand Treatments for Bladder Cancer   Meat, Especially If It’s Well Done, May Increase Risk of Bladder Cancer   New Investigational Treatment for Bladder Cancer, Identified with New Research Model   Arsenic cancer risk still high decades later in Chile region   New treatment option studied for bladder cancer   Delaying bladder cancer surgery increases mortality   Stanford computer algorithm used to identify bladder cancer marker   Bladder cancer patients rarely receive recommended care   New made-in-Canada therapy for bladder cancer shows promising results   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   Consumption of Cultured Milk Products May Reduce Bladder Cancer Risk   Estrogen use tied to bladder control problems   Robotic Surgery Extends Benefits to Bladder Cancer Patients   Survival and Response to Therapy of Non-Invasive Bladder Cancer Patients   New Bladder Cancer Therapy for Patients Unresponsive to Standard Treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]